ICYMI: Chairman Walden on #FDARA Becoming Law
Today, President Trump signed H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, into law. FDARA is the product of bipartisan and bicameral negotiations that will deliver new cures and therapies, maintain and grow our biopharmaceutical jobs in America, and help speed up the review and approval of new drugs and devices.
Highlighting these vital elements, Energy and Commerce Committee Chairman Greg Walden (R-OR) made his first post on the committee’s new Medium account to explain why FDARA is a win.
FDARA is a Win
By: Chairman Greg Walden
Today, President Trump signed H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017 into law. And because it’s likely not one of the health care bills you’ve heard about this year, here’s what you need to know about this bipartisan bill that is now law.
FDARA is a win for patients and the millions of Americans working to create new cures and therapies. The bill is composed of four individual user fee programs, that packaged together will deliver results for patients and ensure we remain the global leader in medical innovation.
Throughout the 21st Century Cures process, we heard about cutting-edge medical innovations that were on their way, but just out of reach. Ensuring these user fee programs are reauthorized will help connect the dots, bringing those innovations to light. Along with Cures, FDARA will deliver hope to patients desperately waiting for that new treatment or medical device.
It will bring lower-cost generic drug alternatives to patients sooner, helping bring down the cost of these often life-saving medications. It will also make the cumbersome FDA review process easier, by modernizing clinical trials and ensuring there’s dedicated staff working to develop, review, and deliver treatments for patients with rare diseases.
Make no mistake: We do all this while maintaining FDA’s gold standard for patient safety.
FDARA is a tremendous win for everyone across the country – the family members and friends who battle disease, the millions of Americans working on the next generation of innovative treatments and medical devices, and our health care system as a whole.
At a time when the media is convinced that Congress isn’t working, we’re proving them wrong. This is a bipartisan victory everyone should be proud of and it ensures this important work continues for years to come, giving patients even more reason to be hopeful.
Click HERE to read the post online.